Seraxis For Profit
.jpg)
Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.
Last Funding Type:
Venture - Series Unknown
Headquarters:
United States
Investors Number:
4
Technology:
Other
Industry:
Regenerative medicine
Estimated Revenue:
$1M to $10M
Total Funding:
$43.7M